Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Lilly divulges several analyses of phase III solanezumab trial data

July 27, 2015

Model created to investigate the role of butyrylcholinesterase in Alzheimer's disease

July 24, 2015

Novel GSM shows promise for the treatment of AD

July 24, 2015

DiffronC Technology targeting NR2F6 shows potential for the treatment of leukemia

July 24, 2015

Encouraging results on S-44858 for the treatment of CNS diseases

July 24, 2015

CNGA2 KO mice show AD-like pathological features

July 23, 2015

New organotypic brain slice culture model helps elucidate Alzheimer's disease pathology

July 23, 2015

Novel mechanism of cone protection by rod-derived cone viability factor identified

July 22, 2015

Panoptes' nonsteroidal drug presented for inflammatory eye diseases

July 22, 2015

New potential biomarkers for early-stage AD

July 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...